All In MedTech

FDA Clearance Tracker · P180046-S062

Axonics Sacral Neuromodulation System (Urinary)

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Dec 19, 2022 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Dec 19, 2022

Approved

Time to decision

81 days

Received Sep 29, 2022. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P180046-S062
Device name
Axonics Sacral Neuromodulation System (Urinary)
Applicant location
Marlborough, MA
Received
Sep 29, 2022
Decided
Dec 19, 2022
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Labeling Change - Indications/instructions/shelf life/tradename
Original approval
P180046

Device type

Device class
Class III
Regulation
21 CFR 876.5270

Every decision under product code EZW

FDA's approval statement

As written in FDA's record.

Approval for updated labeling information

Source documents

Other decisions for Boston Scientific Corporation

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.